South Africa’s drugs regulator to start assessing Sinovac COVID-19 vaccine

PUBLISHED: Fri, 12 Mar 2021 07:01:18 GMT

JOHANNESBURG, March 12 (Reuters) – South Africa’s medicines regulator SAHPRA said on Friday that it had received documentation for the COVID-19 vaccine developed by China’s Sinovac.

It added in a statement that it would now start evaluating the data and assessing the efficacy of the vaccine. (Reporting by Alexander Winning; Editing by Christopher Cushing)

(c) Copyright Thomson Reuters 2021. Click For Restrictions –

Sign Up for Our Newsletter Daily Update
Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent.
Get this delivered to your inbox, and more info about about our products and services. By signing up for newsletters, you are agreeing to our Terms of Use and Privacy Policy.